Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Loss of heterozygosity of D9S162: molecular predictor for treatment response in oral carcinoma.

Oral oncology - 1 Jul 2011

Murali Abitha, Sailasree R, Sebastian Paul, Rejnish Kumar R, Varghese Bipin T, Kannan S

Abstract excerpt

Inspite of improvements in treatment regimen of oral cancer, locoregional recurrence rates and overall mortality have remained unchanged over the years. This study therefore focused on microsatellite alterations in 9p21 loci, as a possible molecular prognostic marker in oral cancer and to identify the correlation between allelic imbalance, if any, with the recurrence in oral cancer. Eighty-one patients, treated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Microsatellite Repeats
Share to Carcinoma, Squamous Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chromosomes, Human, Pair 9

Share to Genes, Tumor Suppressor

Share to Genetic Markers

Share to Loss of Heterozygosity

Share to Mouth Neoplasms

Share to Neoplasm Recurrence, Local

Source

Identifiers

PMID: 21592845
DOI: 10.1016/j.oraloncology.2011.04.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Loss of heterozygosity of D9S162: molecular predictor for treatment response in oral carcinoma.PMID 21592845Read ↗

Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder.Semantic proximity Read ↗

Loss of heterozygosity at the 9p21-24 region and identification of BRM as a candidate tumor suppressor gene in head and neck squamous cell carcinoma.Semantic proximity Read ↗

Loss of P16 expression and chromosome 9p21 LOH in predicting outcome of patients affected by superficial bladder cancer.Semantic proximity Read ↗

3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites.Semantic proximity Read ↗

Loss of chromosome 9p21 and decreased p16 expression correlate with malignant gastrointestinal stromal tumor.Semantic proximity Read ↗

Association between miRNA-binding site polymorphisms in double-strand break repair genes and risk of recurrence in patients with squamous cell carcinomas of the non-oropharynx.Semantic proximity Read ↗

The prognostic significance of allelic imbalance at key chromosomal loci in oral cancer.Semantic proximity Read ↗

Increased genetic damage in oral leukoplakia from high risk sitesSemantic proximity Read ↗

Prognostic implications of loss of heterozygosity at 8p21 and 9p21 in head and neck squamous cell carcinoma.Semantic proximity Read ↗

Analysis of chromosome 9p21 deletion and p16 gene mutation in salivary gland carcinomas.Semantic proximity Read ↗

Clinical significance of genome-wide minimally deleted regions in oral squamous cell carcinomas.Semantic proximity Read ↗

Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.